Director / Sr. Director Pharma Partnering Transactions
Roche
Basel, Switzerland
On-site
Pharmaceutical licensing and collaboration deals
Deal strategy and execution
Negotiating complex licensing or m&a deals
Roche is seeking a Director/Sr. Director for Pharma Partnering Transactions in Basel, Switzerland, to lead strategic partnerships and licensing projects within the biopharma sector. The ideal candidate should have extensive experience in pharma/biotech transactions, strong negotiation skills, and a collaborative mindset
Job Summary
The Corporate Business Development organization supports Roche and Genentech partnerships worldwide, encompassing R&D assets, technologies (both biotech and digital), and commercial deals.
As a member of the Partnering Transaction Group, you will be an integral part of deal teams to structure and negotiate high-impact deals, and shape the direction of our global partnerships.
Roche is dedicated to driving groundbreaking science and technology that transforms patients' lives, and external innovation is a cornerstone of its R&D strategy.
Matching Summary
Match Score: 85
Roche is seeking a Director/Sr. Director for Pharma Partnering Transactions in Basel, Switzerland, to lead strategic partnerships and licensing projects within the biopharma sector. The ideal candidate should have extensive experience in pharma/biotech transactions, strong negotiation skills, and a collaborative mindset.
Skills & Requirements
Must-have
pharmaceutical licensing and collaboration deals
deal strategy and execution
negotiating complex licensing or M&A deals
biopharma executive teams
strategic partnerships and licensing projects
Nice-to-have
personal expression
open dialogue
genuine connections
collaborative mindset
advanced professional judgment
Key Requirements
Advanced degree in Science, Business, Finance, Law, or a related area
Minimum of 10 years of experience in the pharma/biotech industry
Minimum of 5 years of specific pharma/biotech transactions-related experience
Significant experience in negotiating complex licensing or M&A deals